Replies to post #150159 on Biotech Values

[biomaven0]

the immune response to the vaccine in the 18- to 49-year-old age group was not inferior when compared with the response in the 60-to 64-year-old group

Inasmuch as vaccines uniformly work better in young adults than in older folks, that result is hardly surprising. Hard for me to see the business case for this trial.

Peter